Finally, there was no evidence of heterogeneity in the association of IGF‐I and risk of overall bladder cancer by sex (pheterogeneity = 0.10), smoking status (pheterogeneity = 0.13) or time between blood collection and diagnosis (pheterogeneity= 0.79) (Table 3). This evidence concerns the gene IGF1 and urinary bladder carcinoma.